S&P500 ETF vs 10X Genomics Inc — how do they compare? S&P500 ETF trades at $747.88, while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, S&P500 ETF nearer its low. Which is the better fit depends on your goals.
| SPY | TXG | |
|---|---|---|
52-Week High | $759.55 | $45.80 |
52-Week Low | $621.75 | $11.34 |
Market Cap | — | $5.48B |
Sector | — | Health |
Enterprise Value | — | $5.02B |
Signals from Pluang's Aura AI — not financial advice
SPY trades at $742.21, down 0.13% with a bearish technical outlook. The S&P 500 index faces pressure, declining 1.6% last week and trading below its 50-day moving average. Recent news highlights concerns about market concentration in tech stocks and elevated valuations, though some analysts see potential for continued gains. A dividend of $1.90 is scheduled for July 2026.
The ETF's outlook is mixed amid technical weakness and valuation debates. While earnings season shows strength, market concentration and fee comparisons with sister funds present risks. The bearish technical signal suggests near-term caution, though long-term index exposure remains a core portfolio strategy for many investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →